For Release 11AM CST
November 3, 2021
The Recurrent Respiratory Papillomatosis Foundation is proud to announce our partnership with the Chan Zuckerberg Initiative (CZI) Rare As One (RAO) program. This program, which lasts three years and includes training, mentoring, capacity building, research and network development, and $600,000 in grants, represents an extraordinary opportunity for the RRPF and will benefit all patients with RRP.
The RRPF’s partnership with CZI RAO will accelerate the development of non-surgical treatment options for RRP, improve access to care, modernize the standards of treatment, and bring us closer to curing the disease. As the premier organization for RRP advocacy and research, we anticipate participation in the program will impact RRP patient outcomes and drive research across the globe.
RRP is honored to be one of the 20 rare disease non-profit organizations, out of 200 applicants, chosen to participate in this round of the CZI RAO program and we look forward to working together to fight rare disease, bringing progress to diagnosis and treatment. For more information on the CZI Rare As One award and the CZI Rare As One press release, please visit CZI Rare As One.